SURFACEN®

Natural, efective and safe

SURFACEN® is a pig lung surfactant for the Respiratory Distress Syndrome
Pharmaceutical Form: Freeze-dried for endotracheal instillation

Registro sanitario en Cuba 0800

Each bulb contains:

Phospholipids ……………. 50,0 mg

Proteins  ………………… 0,3 a 0,7 mg

Other lipids ……………  2,3 a 3,3 mg

Sodium Chloride ……… 18,0mg

Its protein content consists of two hydrophobic proteins (SP-B and SP-C) of low molecular weight associated with the surfactant. It does not contain other hydrophilic proteins associated with the surfactant such as SP-A and SP-D.
Presentation: Box containing four bulbs | Stability: 24 months.
This drug is produced under the international guidelines of Good Manufacturing Practices (GMP) and Good Laboratory Practices (GLP). The manufacture of the Active Pharmaceutical Ingredient (API), the evaluation of the final product, the batch release, storage and distribution are carried out at the National Center for Animal and Plant Health (CENSA); and the aseptic process: formulation, filling, freeze-drying, visual inspection, packaging and sampling at the National Center of Biological Products (BioCen), both institutions located in Mayabeque province, Cuba.

Therapeutic Indication

SURFACEN® is indicated for the treatment of the Newborn Respiratory Distress Syndrome (Hyaline Membrane Disease, HMD), and in adults, for the Acute Respiratory Distress Syndrome (ARDS).

SURFACEN® has contributed to the reduction of infant mortality (0.2 per thousand born alive) by the Hyaline Membrane disease of since it was registered in Cuba in 1995 to the present.

For further information

Lic. Odalys Uffo Reinosa, Dr.C.

Tel.: (5347) 863897 – 849166

Fax: (5347) 863206

Similar Posts

Recent News

(Español) Visitan el CENSA los doctores Luis E. Pocasangre Enamorado, Líder por Costa Rica del proyecto MUSA y Joaquín Calderón Vargas, Jefe del Laboratorio de Ciencias, ambos del Earth University, de Costa Rica

Sorry, this entry is only available in European Spanish. For the sake of viewer convenience, the content is shown below in the alternative language. You may click the link to switch the active language. Durante […]

Read more

Course-Workshop “FROM ACADEMIA TO INDUSTRY”: Experiences in the development and application of bioproducts for the management of agricultural pests

The National Center for Animal and Plant Health (CENSA) and BiotorLab, a Nicaraguan company, are celebrating 10 years of strategic alliance. For this reason, the Course-Workshop “FROM ACADEMIA TO INDUSTRY”: Experiences in the development and […]

Read more

(Español) Ratifican al Centro Nacional de Sanidad Agropecuaria, condición Vanguardia Nacional.

Sorry, this entry is only available in European Spanish. For the sake of viewer convenience, the content is shown below in the alternative language. You may click the link to switch the active language. En […]

Read more

CENSA participated in the Panel on South-South Cooperation of the 37th session of the Economic Commission for Latin America and the Caribbean (ECLAC)

Researchers from CENSA participated in the Panel on South-South Cooperation of the 37th session of ECLAC, which was held on May 7th, 2018, at Palacio de las Convenciones, Havana, Cuba. The work experience developed from […]

Read more